Editorial
doi: 10.1097/00005072-199710000-00002.
Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease
- PMID: 9329452
- DOI: 10.1097/00005072-199710000-00002
Item in Clipboard
Editorial
Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease
J Neuropathol Exp Neurol.
1997 Oct.
No abstract available
Similar articles
-
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2. Neurobiol Aging. 1997. PMID: 9330978 Review.
-
Diagnostic criteria for the neuropathological assessment of Alzheimer's disease: current status and major issues.Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S43-50. doi: 10.1016/s0197-4580(97)00068-7. Neurobiol Aging. 1997. PMID: 9330984 Review.
-
Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.Alzheimers Dement. 2011 May;7(3):253-6. doi: 10.1016/j.jalz.2011.04.003. Alzheimers Dement. 2011. PMID: 21575869 No abstract available.
-
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.Alzheimers Dement. 2012 Jan;8(1):1-13. doi: 10.1016/j.jalz.2011.10.007. Alzheimers Dement. 2012. PMID: 22265587 Free PMC article.
-
Neuropathology of older persons without cognitive impairment from two community-based studies.Neurology. 2006 Jun 27;66(12):1837-44. doi: 10.1212/01.wnl.0000219668.47116.e6. Neurology. 2006. PMID: 16801647 Clinical Trial.
Cited by
-
Nucleolar PARP-1 Expression Is Decreased in Alzheimer's Disease: Consequences for Epigenetic Regulation of rDNA and Cognition.Neural Plast. 2016;2016:8987928. doi: 10.1155/2016/8987928. Epub 2016 Feb 29. Neural Plast. 2016. PMID: 27034851 Free PMC article.
-
Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms.Arch Neurol. 2012 Aug;69(8):1018-25. doi: 10.1001/archneurol.2012.26. Arch Neurol. 2012. PMID: 22490326 Free PMC article.
-
Clinicopathologic study of Alzheimer's disease: Alzheimer mimics.J Alzheimers Dis. 2013;35(4):799-811. doi: 10.3233/JAD-121594. J Alzheimers Dis. 2013. PMID: 23481687 Free PMC article.
-
Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.J Neurosci. 2002 Sep 15;22(18):7873-8. doi: 10.1523/JNEUROSCI.22-18-07873.2002. J Neurosci. 2002. PMID: 12223540 Free PMC article.
-
Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease.Mol Neurodegener. 2007 Jan 22;2:2. doi: 10.1186/1750-1326-2-2. Mol Neurodegener. 2007. PMID: 17241462 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
